Meyer Colin John - Net Worth and Insider Trading
Meyer Colin John Net Worth
The estimated net worth of Meyer Colin John is at least $14 Million dollars as of 2024-05-05. Meyer Colin John is the Chief Innovation Officer of Reata Pharmaceuticals Inc and owns about 81,633 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $14 Million. Details can be seen in Meyer Colin John's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Meyer Colin John has not made any transactions after 2023-08-16 and currently still holds the listed stock(s).
Transaction Summary of Meyer Colin John
Meyer Colin John Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Meyer Colin John owns 1 companies in total, including Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Meyer Colin John’s form 4 insider trades.
Insider Ownership Summary of Meyer Colin John
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-08-16 | See Remarks |
Meyer Colin John Latest Holdings Summary
Meyer Colin John currently owns a total of 1 stock. Meyer Colin John owns 81,633 shares of Reata Pharmaceuticals Inc (RETA) as of August 16, 2023, with a value of $14 Million.
Latest Holdings of Meyer Colin John
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-08-16 | 81,633 | 172.36 | 14,070,264 |
Holding Weightings of Meyer Colin John
Meyer Colin John Form 4 Trading Tracker
According to the SEC Form 4 filings, Meyer Colin John has made a total of 7 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 2,740 shares on August 16, 2023, which brought Meyer Colin John around $463,060.
Insider Trading History of Meyer Colin John
- 1
Meyer Colin John Trading Performance
GuruFocus tracks the stock performance after each of Meyer Colin John's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Meyer Colin John is 62.31%. GuruFocus also compares Meyer Colin John's trading performance to market benchmark return within the same time period. The performance of stocks bought by Meyer Colin John within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Meyer Colin John's insider trading performs compared to the benchmark.
Performance of Meyer Colin John
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 59.42 | | | | | |
| Relative Return to S&P 500(%) | 60.23 | | | | | |
Meyer Colin John Ownership Network
Meyer Colin John Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
Meyer Colin John is the See Remarks of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
Over the past 18 months, Meyer Colin John made 4 insider transaction in Reata Pharmaceuticals Inc (RETA) with a net sale of 103,516. Other recent insider transactions involving Reata Pharmaceuticals Inc (RETA) include a net sale of 185,892 shares made by Manmeet Singh Soni , a net sale of 150,995 shares made by Dawn Carter Bir , and a net sale of 2,880 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 530,967 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,967 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
Meyer Colin John Mailing Address
Above is the net worth, insider trading, and ownership report for Meyer Colin John. You might contact Meyer Colin John via mailing address: C/o Reata Pharmaceuticals, Inc., 2801 Gateway Dr. Suite 150, Irving Tx 75063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
